Effect of estrogen receptor α binding on functional DNA methylation in breast cancer

Epigenetics

Volumn 9, Issue 4, 2014, Pages 523-532

  Ung, Matthew ^a   Ma, Xiaotu ^b   Johnson, Kevin C ^a   Christensen, Brock C ^a   Cheng, Chao ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Breast cancer; ChIP seq; Differential gene expression; Differential methylation; DNase; Estrogen receptor and ; Hypersensitivity; Transcription factor

Indexed keywords

DEOXYRIBONUCLEASE I; ESTROGEN RECEPTOR ALPHA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR SUZ 12; TRANSCRIPTOME; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR ALPHA, HUMAN; FOXA1 PROTEIN, HUMAN; GATA1 PROTEIN, HUMAN; POLYCOMB REPRESSIVE COMPLEX 2; SUZ12 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE; GENE EXPRESSION; HUMAN; PROTEIN DNA BINDING; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; METABOLISM;

BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; POLYCOMB REPRESSIVE COMPLEX 2; TRANSCRIPTOME;

EID: 84899145981     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.27688     Document Type: Article

References (45)

1. Barlow DP. Genomic imprinting: a mammalian epigenetic discovery model. Annu Rev Genet 2011; 45:379-403; PMID:21942369; http://dx.doi. org/10.1146/annurev-genet-110410-132459
2. Riggs AD. X inactivation, differentiation, and DNA methylation. Cytogenet Cell Genet 1975; 14:9-25; PMID:1093816; http://dx.doi. org/10.1159/000130315
3. Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997; 13:335-40; PMID:9260521; http:// dx.doi.org/10.1016/S0168-9525(97)01181-5
4. Meissner A. Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol 2010; 28:1079-88; PMID:20944600; http://dx.doi. org/10.1038/nbt.1684
5. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007; 447:425-32; PMID:17522676; http://dx.doi. org/10.1038/nature05918
6. Martin M, Herceg Z. From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms. Genome Med 2012; 4:8; PMID:22293089; http://dx.doi. org/10.1186/gm307
7. Baylin SB, Jones PA. A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer 2011; 11:726-34; PMID:21941284; http://dx.doi.org/10.1038/nrc3130
8. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33(Suppl):245-54; PMID:12610534; http://dx.doi. org/10.1038/ng1089
9. Berman BP, Weisenberger DJ, Aman JF, Hinoue T, Ramjan Z, Liu Y, Noushmehr H, Lange CP, van Dijk CM, Tollenaar RA, et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear laminaassociated domains. Nat Genet 2012; 44:40-6; PMID:22120008; http://dx.doi.org/10.1038/ng.969
10. Hartmann O, Spyratos F, Harbeck N, Dietrich D, Fassbender A, Schmitt M, Eppenberger-Castori S, Vuaroqueaux V, Lerebours F, Welzel K, et al. DNA methylation markers predict outcome in nodepositive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. Clin Cancer Res 2009; 15:315-23; PMID:19118060; http://dx.doi.org/10.1158/1078-0432.CCR-08-0166
11. Cancer Genome Atlas N; Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490:61-70; PMID:23000897; http://dx.doi.org/10.1038/ nature11412
12. Hill VK, Ricketts C, Bieche I, Vacher S, Gentle D, Lewis C, Maher ER, Latif F. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res 2011; 71:2988-99; PMID:21363912; http://dx.doi.org/10.1158/0008-5472.CAN-10-4026
13. Rozowsky J, Euskirchen G, Auerbach RK, Zhang ZD, Gibson T, Bjornson R, Carriero N, Snyder M, Gerstein MB. PeakSeq enables systematic scoring of ChIP-seq experiments relative to controls. Nat Biotechnol 2009; 27:66-75; PMID:19122651; http://dx.doi.org/10.1038/nbt.1518
14. Fackler MJ, Umbricht CB, Williams D, Argani P, Cruz LA, Merino VF, Teo WW, Zhang Z, Huang P, Visvananthan K, et al. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res 2011; 71:6195-207; PMID:21825015; http://dx.doi.org/10.1158/0008-5472.CAN-11-1630
15. Fang F, Turcan S, Rimner A, Kaufman A, Giri D, Morris LG, Shen R, Seshan V, Mo Q, Heguy A, et al. Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Transl Med 2011; 3:75ra25; PMID:21430268; http://dx.doi. org/10.1126/scitranslmed.3001875
16. Dedeurwaerder S, Desmedt C, Calonne E, Singhal SK, Haibe-Kains B, Defrance M, Michiels S, Volkmar M, Deplus R, Luciani J, et al. DNA methylation profiling reveals a predominant immune component in breast cancers. EMBO Mol Med 2011; 3:726-41; PMID:21910250; http://dx.doi.org/10.1002/ emmm.201100801
17. Bediaga N, Acha-Sagredo A, Guerra I, Viguri A, Albaina C, Ruiz Diaz I, et al. DNA methylation epigenotypes in breast cancer molecular subtypes. BCR 2010; 12.
18. Holm K, Hegardt C, Staaf J, Vallon-Christersson J, Jonsson G, Olsson H, et al. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns. BCR 2010; 12.
19. Martens JW, Margossian AL, Schmitt M, Foekens J, Harbeck N. DNA methylation as a biomarker in breast cancer. Future Oncol 2009; 5:1245-56; PMID:19852739; http://dx.doi.org/10.2217/ fon.09.89
20. Ulirsch J, Fan C, Knafl G, Wu MJ, Coleman B, Perou CM, Swift-Scanlan T. Vimentin DNA methylation predicts survival in breast cancer. Breast Cancer Res Treat 2013; 137:383-96; PMID:23239149; http:// dx.doi.org/10.1007/s10549-012-2353-5
21. Choy M-K, Movassagh M, Goh H-G, Bennett MR, Down TA, Foo RS. Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated. BMC Genomics 2010; 11:519; PMID:20875111; http://dx.doi. org/10.1186/1471-2164-11-519
22. Comb M, Goodman HM. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res 1990; 18:3975-82; PMID:1695733; http://dx.doi. org/10.1093/nar/18.13.3975
23. Miranda TB, Jones PA. DNA methylation: the nuts and bolts of repression. J Cell Physiol 2007; 213:384-90; PMID:17708532; http://dx.doi.org/10.1002/ jcp.21224
24. Prendergast GC, Lawe D, Ziff EB. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 1991; 65:395-407; PMID:1840505; http://dx.doi. org/10.1016/0092-8674(91)90457-A
25. Höller M, Westin G, Jiricny J, Schaffner W. Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev 1988; 2:1127-35; PMID:3056778; http://dx.doi.org/10.1101/ gad.2.9.1127
26. Filion GJ, Zhenilo S, Salozhin S, Yamada D, Prokhortchouk E, Defossez P-A. A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol Cell Biol 2006; 26:169-81; PMID:16354688; http://dx.doi.org/10.1128/ MCB.26.1.169-181.2006
27. Hashimshony T, Zhang J, Keshet I, Bustin M, Cedar H. The role of DNA methylation in setting up chromatin structure during development. Nat Genet 2003; 34:187-92; PMID:12740577; http://dx.doi. org/10.1038/ng1158
28. Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998; 18:6538-47; PMID:9774669
29. Johnson LM, Bostick M, Zhang X, Kraft E, Henderson I, Callis J, Jacobsen SE. The SRA methyl-cytosine-binding domain links DNA and histone methylation. Curr Biol 2007; 17:379-84; PMID:17239600; http://dx.doi.org/10.1016/j. cub.2007.01.009
30. Rottach A, Frauer C, Pichler G, Bonapace IM, Spada F, Leonhardt H. The multi-domain protein Np95 connects DNA methylation and histone modification. Nucleic Acids Res 2010; 38:1796-804; PMID:20026581; http://dx.doi.org/10.1093/nar/ gkp1152
31. Prokhortchouk A, Hendrich B, Jørgensen H, Ruzov A, Wilm M, Georgiev G, Bird A, Prokhortchouk E. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev 2001; 15:1613-8; PMID:11445535; http://dx.doi.org/10.1101/gad.198501
32. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13:484-92; PMID:22641018; http://dx.doi. org/10.1038/nrg3230
33. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, et al. The accessible chromatin landscape of the human genome. Nature 2012; 489:75-82; PMID:22955617; http://dx.doi. org/10.1038/nature11232
34. Szyf M. DNA methylation signatures for breast cancer classification and prognosis. Genome Med 2012; 4:26; PMID:22494847; http://dx.doi.org/10.1186/ gm325
35. Piva R, Rimondi AP, Hanau S, Maestri I, Alvisi A, Kumar VL, del Senno L. Different methylation of oestrogen receptor DNA in human breast carcinomas with and without oestrogen receptor. Br J Cancer 1990; 61:270-5; PMID:2155643; http://dx.doi. org/10.1038/bjc.1990.50
36. Li L, Lee KM, Han W, Choi JY, Lee JY, Kang GH, Park SK, Noh DY, Yoo KY, Kang D. Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer. Hum Mol Genet 2010; 19:4273-7; PMID:20724461; http:// dx.doi.org/10.1093/hmg/ddq351
37. Widschwendter M, Siegmund KD, Müller HM, Fiegl H, Marth C, Müller-Holzner E, Jones PA, Laird PW. Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res 2004; 64:3807-13; PMID:15172987; http://dx.doi.org/10.1158/0008-5472.CAN-03-3852
38. Ruike Y, Imanaka Y, Sato F, Shimizu K, Tsujimoto G. Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics 2010; 11:137; PMID:20181289; http://dx.doi. org/10.1186/1471-2164-11-137
39. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M; ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489:57-74; PMID:22955616; http://dx.doi.org/10.1038/ nature11247
40. Theodorou V, Stark R, Menon S, Carroll JS. GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility. Genome Res 2013; 23:12-22; PMID:23172872; http://dx.doi. org/10.1101/gr.139469.112
41. Watters RJ, Benos PV, Oesterreich S. To bind or not to bind--FoxA1 determines estrogen receptor action in breast cancer progression. Breast Cancer Res 2012; 14:312; PMID:22713214; http://dx.doi. org/10.1186/bcr3146
42. Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011; 469:343-9; PMID:21248841; http://dx.doi.org/10.1038/ nature09784
43. Kennison JA. The Polycomb and trithorax group proteins of Drosophila: trans-regulators of homeotic gene function. Annu Rev Genet 1995; 29:289-303; PMID:8825476; http://dx.doi.org/10.1146/annurev. ge.29.120195.001445
44. Chinnadurai G. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell 2002; 9:213-24; PMID:11864595; http://dx.doi.org/10.1016/ S1097-2765(02)00443-4
45. Aran D, Sabato S, Hellman A. DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes. Genome Biol 2013; 14:R21; PMID:23497655; http://dx.doi.org/10.1186/ gb-2013-14-3-r21